Article
A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation.
Journal of virology - 1 May 2003
García-Lerma J Gerardo, MacInnes Hamish, Bennett Diane, Reid Patrick, Nidtha Soumya, Weinstock Hillard, Kaplan Jonathan E, Heneine Walid
Abstract excerpt
Stavudine (d4T) and zidovudine (AZT) are thymidine analogs widely used in the treatment of human immunodeficiency virus type 1 (HIV-1)-infected persons. Resistance to d4T is not fully understood, although the selection of AZT resistance mutations in patients treated with d4T suggests that both drugs have similar pathways of resistance. Through the analysis of genotypic changes in nine recombinant viruses cultured...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
